Advertisement

Uncategorized

The global hospital-associated bacterial infections market is forecast to reach $1.4 billion by 2016, indicated a reduced growth rate due to patent expiries of major blockbusters, which are expected to decrease the annual cost of therapy after 2009, according to…

Injectable drug shortages are forcing physicians to resort to other alternatives that are less safe or postpone or cancel procedures altogether, posing serious patient safety risks or in some cases death, according to a USA Today news report.

Advertisement
Advertisement